A 1-year, randomized, double-blind safety study of long-term treatment of a new gel formulation containing calcipotriene plus betamethasone dipropionate in scalp psoriasis

被引：0

作者：

Luger, Thomas ^{[1
]}

Kidson, Paul ^{[2
]}

Cambazard, Francois ^{[3
]}

Larsen, Frederik Gronhoj ^{[4
]}

机构：

[1] Univ Clin Munster, Munster, Germany

[2] LEO Pharma inc, Thornhill, ON, Canada

[3] CHU ST Etiene, Hop Nord, St Etienne, France

[4] Dermatol Practice, Frederiksberg, Denmark

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2008年 / 58卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：AB134 / AB134

页数：1

共 50 条

[21] A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects
Cercato, C.
Roizenblatt, V. A.
Leanca, C. C.
Segal, A.
Lopes Filho, A. P.
Mancini, M. C.
Halpern, A.
INTERNATIONAL JOURNAL OF OBESITY, 2009, 33 (08) : 857 - 865
[22] In vivo multiphoton microscopy evaluation of long-term effects of retinol and retinoic acid on photodamaged skin: A 1-year randomized, double-blind, controlled study
Tancrede-Bohin, Emmanuelle
Pena, Ana-Maria
Parent, Nathalie
Dalmaschio, Raquel
Brizion, Sebastien
Baldeweck, Therese
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB25 - AB25
[23] Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up
O'Connor, Brian J.
Kilfeather, Stephen
Cheung, David
Kafe, Henri
Blagden, Mark D.
Schlosser, Noel
Ayres, Jon G.
Weber, Hans-Jochen
Engelstaetter, Renate
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (17) : 2791 - 2803
[24] Long-term safety of ramelteon treatment in adults with chronic insomnia: A 1-year study
Richardson, G.
Wang-Weigand, S.
Zhang, J.
DeMicco, M.
SLEEP, 2006, 29 : A233 - A233
[25] Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial
Guenther, L
Cambazard, F
Van de Kerkhof, PCM
Snellman, E
Kragballe, K
Chu, AC
Tegner, E
Garcia-Diez, A
Springborg, J
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) : 316 - 323
[26] Role of orlistat in the treatment of obese patients with type 2 diabetes - A 1-year randomized double-blind study
Hollander, PA
Elbein, SC
Hirsch, IB
Kelley, D
McGill, J
Taylor, T
Weiss, SR
Crockett, SE
Kaplan, RA
Comstock, J
Lucas, CP
Lodewick, PA
Canovatchel, W
Chung, J
Hauptman, J
DIABETES CARE, 1998, 21 (08) : 1288 - 1294
[27] Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study
Unfer, V
Casini, ML
Costabile, L
Mignosa, M
Gerli, S
Di Renzo, GC
FERTILITY AND STERILITY, 2004, 82 (01) : 145 - 148
[28] Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study
Thaci, D.
Papp, K.
Marcoux, D.
Weibel, L.
Pinter, A.
Ghislain, P. -D.
Landells, I.
Hoeger, P. H.
Unnebrink, K.
Seyger, M. M. B.
Williams, D. A.
Rubant, S.
Philipp, S.
BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (06) : 1177 - 1189
[29] Long-term efficacy and safety of secukinumab in Japanese patients with moderate to severe plaque psoriasis: 3-year results of a double-blind extension study
Okubo, Yukari
Ohtsuki, Mamitaro
Morita, Akimichi
Yamaguchi, Masako
Shima, Tomohiro
Tani, Yumiko
Nakagawa, Hidemi
JOURNAL OF DERMATOLOGY, 2019, 46 (03): : 186 - 192
[30] Matching-Adjusted Indirect Comparison of Long-Term Efficacy and Safety Outcomes for Calcipotriol Plus Betamethasone Dipropionate Foam Versus Halobetasol Proprionate Plus Tazarotene Lotion in the Treatment of Plaque Psoriasis
Adam, David N.
Bernasconi, Marie Y. Jablonski
Thoning, Henrik
Wu, Jashin J.
DERMATOLOGY AND THERAPY, 2022, 12 (11) : 2589 - 2600

← 1 2 3 4 5 →